Search results for "Perth"

showing 10 items of 156 documents

Congenital hypothyroidism in a child with unsuspected familial dysalbuminemic hyperthyroxinemia caused by a mutation (R218H) in the human albumin gene

2001

We found familial dysalbuminemic hyperthyroxinemia (FDH) in a 5-month-old boy with congenital hypothyroidism (CH) who had a blood thyrotropin (TSH) level of 479 mU/L but normal total serum thyroxine (T4) and higher than normal total triiodothyronine (T3) levels. Thyroid hormone substitution began at 5 weeks of age when T4 and T3 concentrations were below normal. Until the age of 5 months, treatment with levothyroxine was suboptimal on the basis of high serum TSH levels despite above-normal T4 levels. FDH was confirmed by isoelectric focusing and testing of other family members. DNA analysis of the patient revealed R218H, a mutation in the serum albumin gene associated with FDH, which was al…

Maleendocrine systemmedicine.medical_specialtyendocrine system diseasesSerum albuminLevothyroxineThyrotropinHypothyroidismAlbuminsInternal medicineCongenital HypothyroidismAlbuminuriaHumansMedicineEuthyroidTriiodothyroninebiologybusiness.industryThyroidAlbuminInfantmedicine.diseaseCongenital hypothyroidismHyperthyroxinemiaThyroxinemedicine.anatomical_structureEndocrinologyFamilial dysalbuminemic hyperthyroxinemiaMutationPediatrics Perinatology and Child Healthbiology.proteinbusinessmedicine.drugThe Journal of Pediatrics
researchProduct

Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism

2007

Although subclinical hyperthyroidism (SCH) has been associated with increased risk of osteoporosis and cardiac arrhythmias, its treatment is still controversial. This study was designed as a prospective, randomized, intervention, control-study with a 1-year follow-up in order to investigate whether normalization of serum TSH in SCH using methimazole has favorable bone and heart clinical effects. Fourteen patients with endogenous SCH (not Graves' disease) were enrolled, 7 (5 women/2 men; group T) were treated with methimazole (2.5-7.5 mg/day), and 7 (5 women/2 men; group C) were followed without treatment; 10 healthy subjects were also included in the study as controls. Serum free-T3 (FT3), …

Malemedicine.medical_specialtyThyroid HormonesBone densityEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisBlood PressureGastroenterologyHyperthyroidismEndocrinologyAntithyroid AgentsBone DensityHeart RateInternal medicineHeart ratemedicineHumansProspective StudiesProspective cohort studySubclinical infectionThyroidbusiness.industryAntithyroid agentThyroidSublinical hyperthyroidismHeartMiddle Agedmedicine.diseaseBlood pressureEndocrinologymedicine.anatomical_structureFemalebusinessFollow-Up Studies
researchProduct

The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats.

1997

The effects of insulin on the rates of glucose disposal were studied in soleus muscles isolated from hyper- or hypothyroid rats. Treatment with triiodothyronine for 5 or 10 days decreased the sensitivity of glycogen synthesis but increased the sensitivity of lactate formation to insulin. The sensitivity of 3-O methylglucose to insulin was increased only after 10 days of treatment and was accompanied by an increase in the sensitivity of 2-deoxyglucose phosphorylation; however, 2-deoxyglucose and glucose 6-phosphate in response to insulin remained unaltered. In hypothyroidism, insulin-stimulated rates of 3-O-methylglucose transport and 2-deoxyglucose phosphorylation were decreased; however, a…

Malemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryBiological Transport ActiveBiologyCarbohydrate metabolismIn Vitro TechniquesBiochemistryHyperthyroidismDinoprostonechemistry.chemical_compoundHypothyroidismInternal medicinemedicineAnimalsInsulinGlycolysisDrug InteractionsLactic AcidPhosphorylationRats WistarGlycogen synthaseMuscle SkeletalHexokinaseInsulinGlucose transporterGeneral MedicineMetabolismRatsCortisoneEndocrinologyGlucosechemistryBasal (medicine)Growth Hormonebiology.proteinTriiodothyronineGlycolysisGlycogenEuropean journal of clinical investigation
researchProduct

Preparation and Characterization of Gold Nanorods Coated with Gellan Gum and Lipoic Acid

2020

Gold nanorods (AuNRs) can combine therapeutic hyperthermia with diagnostic features, representing a smart choice to address personalized cancer treatments. In this regard, a crucial quest is the selection of the right biocompatible coating agent able to stabilize them in the physiological environment, further endowing the possibility to load bioactive molecules and/or targeting moieties. Therefore, AuNRs optical properties can be successfully merged with advantageous materials features to obtain selective photothermal therapy (PTT) systems. Here, the natural materials lipoic acid (LA) and the polysaccharide gellan gum (GG) were chosen to prepare three types of stabilized gold nanorods, usin…

Materials sciencephotothermal therapy02 engineering and technologyengineering.material010402 general chemistry01 natural scienceslcsh:Technologylcsh:Chemistrychemistry.chemical_compoundCoatinggold nanorodGeneral Materials ScienceSurface chargeInstrumentationlcsh:QH301-705.5Fluid Flow and Transfer Processeslcsh:TProcess Chemistry and TechnologyPhotothermal effectGeneral Engineeringpolysaccharide coatingPhotothermal therapy021001 nanoscience & nanotechnologylipoic acidhyperthermiagold nanorodsGellan gumlcsh:QC1-9990104 chemical sciencesComputer Science ApplicationsLipoic acidChemical engineeringchemistrylcsh:Biology (General)lcsh:QD1-999Covalent bondlcsh:TA1-2040engineeringNanorod0210 nano-technologylcsh:Engineering (General). Civil engineering (General)lcsh:Physicsgellan gum
researchProduct

Incidence and Clinical Implications of Autoimmune Thyroiditis in the Development of Acne in Young Patients

2021

Autoimmune thyroiditis (AIT) is on the rise among the population, and is frequently associated with patients with acne vulgaris, especially females aged between 18–55 years old. The connection between the two is not fully elucidated. In this study, 236 patients diagnosed with acne in the dermatological office of the private Pelican Hospital and in few private dermatological offices from Oradea, Romania, during January 2018–December 2020, aged between 12 and 55 years old, were endocrinologically investigated to determine AIT and its influence on the severity of the acne. The values for the thyroid antibodies and thyroid-stimulating hormone (TSH) were determined for all of the subjects. The f…

Medicine (General)medicine.medical_specialtyClinical BiochemistryPopulation030209 endocrinology & metabolismArticleAutoimmune thyroiditis030207 dermatology & venereal diseases03 medical and health sciencesR5-9200302 clinical medicineacne vulgarishyperthyroidismMedicineIn patienteducationAcneeducation.field_of_studybusiness.industryIncidence (epidemiology)autoimmune thyroiditismedicine.diseaseDermatologyAnti-thyroid autoantibodiesskin disordersdermatologyhypothyroidismbusinessHormoneDiagnostics
researchProduct

Buccal delivery of Methimazole as an alternative means to optimize drug bioavailability: permeation studies and matrix system design

2012

The aim of this study was to investigate the potential for systemic administration of Methimazole (MMI) through the buccal mucosa as an alternative route for drug delivery. Considering that the most important restriction in buccal drug delivery could be the low permeability of the mucosa, the ability of MMI to cross the mucosal barrier was assessed. Permeation of MMI through porcine buccal mucosa was investigated ex vivo using Franz type diffusion cells, buffer solution simulating saliva or natural human saliva as donor phase. The collected data suggested that buccal mucosa does not hinder MMI diffusion and the drug crosses the membrane (Js = 0.068 mg cm-2 h-1 and Kp = 0.065 cm h-1). Matrix…

MethimazoleSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPorcine buccal mucosaBuccal tabletsTransbuccal permeationHyperthyroidismEudragit® RS 100
researchProduct

Substrate pathways and mechanisms of inhibition in the sulfur oxygenase reductase of Acidianus ambivalens

2011

Background: The sulfur oxygenase reductase (SOR) is the initial enzyme of the sulfur oxidation pathway in the thermoacidophilic Archaeon Acidianus ambivalens. The SOR catalyzes an oxygen-dependent sulfur disproportionation to H2S, sulfite and thiosulfate. The spherical, hollow, cytoplasmic enzyme is composed of 24 identical subunits with an active site pocket each comprising a mononuclear non-heme iron site and a cysteine persulfide. Substrate access and product exit occur via apolar chimney-like protrusions at the four-fold symmetry axes, via narrow polar pores at the three-fold symmetry axes and via narrow apolar pores within in each subunit. In order to investigate the function of the po…

Microbiology (medical)StereochemistrySulfur metabolismlcsh:QR1-502ReductaseMicrobiologylcsh:Microbiologychemistry.chemical_compoundOxidoreductaseStructural BiologySite-directed mutagenesisOriginal ResearchX-ray crystallographychemistry.chemical_classificationSite-directed mutagenesisbiologySulfur metabolismActive siteSubstrate (chemistry)ArchaeaEnzyme assaychemistryBiochemistryHyperthermophileIodoacetamidebiology.proteinFrontiers in Microbiology
researchProduct

In vivo efficacy of verteporfin loaded gold nanorods for combined photothermal/photodynamic colon cancer therapy.

2022

The high incidence of cancer recurrences and the frequent occurrence of multidrug resistance often stem from a poorly selective and inefficient antineoplastic therapy, responsible for the onset of undesired side effects as well. A combination of minimal-invasive approaches could thus be a useful strategy to surmount these shortcomings, achieving a safe and solid cancer therapy. Herein, a multi-therapeutic nanotool was designed by merging the photothermal properties of gold nanorods (AuNRs) with the photodynamic activity of the photosensitizer ver-teporfin. AuNRs were coated with the natural materials lipoic acid and gellan gum (AuNRs_LA,GG) and subse-quently loaded with verteporfin (AuNRs_L…

NanotubesHuman colon cancerPharmaceutical ScienceVerteporfinHyperthermia InducedPhototherapyGold nanorodsPhotothermal therapyGellan gumPhotodynamic therapyMiceCell Line TumorColonic NeoplasmsAnimalsHumansGoldInternational journal of pharmaceutics
researchProduct

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

2014

Objective To analyze the feasibility of laparoscopic/robotic secondary cytoreductive surgery and hyperthermic intraperitoneal intra-operative chemotherapy (SCS + HIPEC) in a retrospective series of isolated platinum sensitive recurrent ovarian cancer. Methods We retrospectively evaluated a consecutive series of ovarian cancer patients with isolated platinum sensitive relapse. Isolated relapse was defined as the presence of a single nodule, in a single anatomic site. In all cases the presence of isolated relapse was assessed at pre-operative FDG-PET/CT scan, and confirmed with staging laparoscopy performed immediately before SCS + HIPEC. Results 84 women with platinum sensitive relapse recei…

OVARIAN CANEROrganoplatinum Compoundsmedicine.medical_treatmentdrug therapy/pathology/surgery/therapyCarcinoma Ovarian EpithelialMultimodal ImagingCohort StudiesObstetrics and gynaecologyNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsInfusions ParenteralNeoplasms Glandular and EpithelialLaparoscopyadministration /&/ dosageTomographyRandomized Controlled Trials as TopicOvarian Neoplasmsmedicine.diagnostic_testObstetrics and GynecologyGlandular and EpithelialMiddle AgedDebulkingCombined Modality TherapyIsolated platinum sensitive relapseX-Ray ComputedOxaliplatinPhase III as TopicOncologyFemalediagnostic usemedicine.drugmedicine.medical_specialtyInfusionsAged Antineoplastic Combined Chemotherapy Protocols; administration /&/ dosage Cisplatin; administration /&/ dosage Clinical Trials; Phase II as Topic Clinical Trials; Phase III as Topic Cohort Studies Combined Modality Therapy Female Fluorodeoxyglucose F18; diagnostic use Humans Hyperthermia; Induced; methods Infusions; Parenteral Middle Aged Minimally Invasive Surgical Procedures Multimodal Imaging Neoplasms; Glandular and Epithelial; drug therapy/pathology/surgery/therapy Organoplatinum Compounds; administration /&/ dosage Ovarian Neoplasms; drug therapy/pathology/surgery/therapy Positron-Emission Tomography Radiopharmaceuticals; diagnostic use Randomized Controlled Trials as Topic Retrospective Studies Tomography; X-Ray Computed ocal; pathologyocalmethodsClinical Trials Phase II as TopicMinimally invasive surgeryOvarian cancerFluorodeoxyglucose F18ParenteralmedicineHumansMinimally Invasive Surgical ProceduresClinical TrialsHyperthermiaAgedRetrospective StudiesCisplatinChemotherapySeries (stratigraphy)HIPECbusiness.industryPhase II as TopicInducedHyperthermia Inducedmedicine.diseaseOxaliplatinSurgeryRoboticSettore MED/40 - GINECOLOGIA E OSTETRICIAClinical Trials Phase III as TopicPositron-Emission TomographyLaparoscopypathologyNeoplasm Recurrence LocalCisplatinRadiopharmaceuticalsbusinessOvarian cancerTomography X-Ray Computed
researchProduct

Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience

2003

The prevalence of superficial transitional cell carcinoma of the bladder (STCCB) is still increasing in spite of improved adjuvant chemotherapic and/or immunoprophylaxis approaches. Thus, there is certainly an urgent need to improve our ability to control this disease. Local hyperthermia has a therapeutical potential for the treatment of many solid tumors, especially when used in combination with other treatments, such as radiation and chemotherapy. In particular, a synergistic or, at least, supra-additive antitumor cell killing effect was documented when local hyperthermia was administered in combination with selected cytostatic drugs. Recently, advances in miniaturized technology have all…

OncologyHyperthermiamedicine.medical_specialtymedicine.medical_treatmentAntineoplastic AgentsInternal medicinemedicineAnimalsHumansChemotherapyBladder cancerUrinary bladderbusiness.industryHyperthermia InducedHematologymedicine.diseaseCombined Modality TherapySurgeryRegimenAdministration IntravesicalTreatment OutcomeCell killingTransitional cell carcinomamedicine.anatomical_structureUrinary Bladder NeoplasmsOncologyintravesical chemotherapy hyperthermia bladder cancerNeoplasm Recurrence LocalbusinessAdjuvantCritical Reviews in Oncology/Hematology
researchProduct